News

Little hope for a flurry of executive orders that revive drug importation and rebate transactions in Medicare

Survey uncovers key trends in biopharma pursuits for sustainable logistics

Addressing continued hurdles in patient adherence

Steady progress is occurring in the global effort to track pharmaceutical distribution, even as new technical and business opportunities appear

PDG will hold a two-day webinar showcasing participating organizations

More warehouse capacity, plus a growing investment in robotics

Passive containers maintain a -20°C temperature spec

Robert Wood Johnson Foundation-sponsored study assesses the situation

Company will invest $1 billion to open 500-700 clinics at its pharmacies over five years

Biopharma companies are investing in field reimbursement staff to reduce patient barriers to therapy by guiding prescribing physicians through specialty therapy access and adherence challenges

Company pitches a mfr-payer-provider-patient collaboration for drug pricing

TransCelerate opens up its network to qualified researchers; Oracle has a new platform

SensiWatch Platform includes analytics and APIs for integrating supply-chain information

Trinity Life Sciences offers a way to measure changing physician practices during the pandemic

Acquisitions jump BMS and Takeda into Top 10; Amgen and Gilead fall out

Also: more innovative cold-chain actions during the Covid-19 pandemic

1.3-million sq. ft to be added in the US and Europe

Move anticipates high-volume Covid-19 vaccine and therapeutics production, amidst other vial-production advances

Guidance for companies starting out on the commercialization path

Extension of the company’s Pathways program seeks to offer a richer and deeper patient interaction

Position highlights the move toward more at-home services

Guidance for companies starting out on the commercialization path

Use of an eBV system can save months of re-verification work and >$100,000 in operational costs

Industry consortium is poised to manage pharma supply-chain interoperability governance

Chain of identity, chain of custody are high priorities for autologous therapies

Service can be multimodal and multi-provider, and is not device-dependent